154 related articles for article (PubMed ID: 34881177)
1. Alpha-L-Fucosidase Has Diagnostic Value in Prostate Cancer With "Gray-Zone PSA" and Inhibits Cancer Progression
Zhang C; Liu J; Chao F; Wang S; Li D; Han D; Xu Z; Xu G; Chen G
Front Oncol; 2021; 11():742354. PubMed ID: 34881177
[TBL] [Abstract][Full Text] [Related]
2. [Preoperative serum α-1-fucosidase as an early-recurrent indicator for hepatocellular carcinoma following curative resection].
Zhou Y; Ma X; Wu J; Zhang C; Wang B; Song B; Guo W; Pan B
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(46):3623-8. PubMed ID: 25622951
[TBL] [Abstract][Full Text] [Related]
3. Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study.
Wang K; Guo W; Li N; Shi J; Zhang C; Lau WY; Wu M; Cheng S
Br J Cancer; 2014 Apr; 110(7):1811-9. PubMed ID: 24569461
[TBL] [Abstract][Full Text] [Related]
4. Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma.
Yu X; Zhang R; Yang T; Zhang M; Xi K; Lin Y; Wen Y; Wang G; Huang Z; Zhang X; Zhang L
J Thorac Dis; 2019 Sep; 11(9):3980-3990. PubMed ID: 31656672
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone.
Xu B; Chen Y; Chen X; Gan L; Zhang Y; Feng J; Yu L
Front Oncol; 2021; 11():730638. PubMed ID: 34722271
[TBL] [Abstract][Full Text] [Related]
7. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.
Lu ZY; Cen C; Shao Z; Chen XH; Xu CF; Li YM
World J Gastroenterol; 2016 Feb; 22(5):1884-90. PubMed ID: 26855548
[TBL] [Abstract][Full Text] [Related]
8. [The value of serum alpha-L-fucosidase activity in the diagnosis of primary liver cancer].
Wei X; Wang S; Rui J
Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):148-50. PubMed ID: 11776645
[TBL] [Abstract][Full Text] [Related]
9. Demystifying Lysosomal α-l-Fucosidase in Liver Cancer-Bearing Mice by Specific Two-Photon Fluorescence Imaging.
Fan N; Li P; Zhou Y; Wu C; Wang X; Liu Z; Tang B
ACS Sens; 2022 Jan; 7(1):71-81. PubMed ID: 34968045
[TBL] [Abstract][Full Text] [Related]
10. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
11. The Value of Preoperative Alpha-L-Fucosidase Levels in Evaluation of Malignancy and Differential Diagnosis of Urothelial Neoplasms.
Chen D; Xing N; Cui Z; Zhang C; Zhang Z; Li D; Yan L
J Oncol; 2020; 2020():6723616. PubMed ID: 32774371
[TBL] [Abstract][Full Text] [Related]
12. Preoperative AFU Is a Useful Serological Prognostic Predictor for Colorectal Liver Oligometastasis Patients Undergoing Hepatic Resection.
Deng Y; Zhao Y; Fan W; Peng J; Luo X; Mo Y; Xiao B; Zhang L; Pan Z
J Cancer; 2019; 10(21):5049-5056. PubMed ID: 31602256
[No Abstract] [Full Text] [Related]
13. Purification and characterization of alpha-L-fucosidase from human primary hepatocarcinoma tissue.
Li C; Qian J; Lin JS
World J Gastroenterol; 2006 Jun; 12(23):3770-5. PubMed ID: 16773698
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer.
Ayude D; Páez De La Cadena M; Martínez-Zorzano VS; Fernández-Briera A; Rodríguez-Berrocal FJ
Oncology; 2003; 64(1):36-45. PubMed ID: 12457030
[TBL] [Abstract][Full Text] [Related]
16. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
[TBL] [Abstract][Full Text] [Related]
17. Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.
Lavaud P; Gravis G; Foulon S; Joly F; Oudard S; Priou F; Latorzeff I; Mourey L; Soulié M; Delva R; Krakowski I; Laguerre B; Théodore C; Ferrero JM; Beuzeboc P; Habibian M; Rolland F; Deplanque G; Pouessel D; Zanetta S; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Tubiana-Mathieu N; Machiels JP; Kouri CE; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Culine S; Boher JM; Tergemina-Clain G; Legoupil C; Fizazi K
Eur Urol; 2018 May; 73(5):696-703. PubMed ID: 29074061
[TBL] [Abstract][Full Text] [Related]
18. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
19. Serum AFU, 5'-NT and AFP as Biomarkers for Primary Hepatocellular Carcinoma Diagnosis.
Junna Z; Gongde C; Jinying X; Xiu Z
Open Med (Wars); 2017; 12():354-358. PubMed ID: 29043300
[TBL] [Abstract][Full Text] [Related]
20. Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity.
Shuang Z; Mao Y; Lin G; Wang J; Huang X; Chen J; Duan F; Li S
Biomed Res Int; 2018; 2018():8182575. PubMed ID: 29682557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]